Macrolive Pharma Private Limited
About Macrolive Pharma Private Limited
Data last updated:
Macrolive Pharma Private Limited is a private limited company based in Ghaziabad, Uttar Pradesh, India. It operates in the x-ray apparatus segment of the healthcare sector. It was incorporated on 04 February 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U33111UP2016PTC076264. Its GSTIN is 09AAKCM1428P2ZW (Uttar Pradesh). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Madhur Rajput and Jaya Rajput.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 959 2nd Floor Shakti Khand – 4 Indirapuram Ghaziabad, Uttar Pradesh, India – 201014.
As per the financials filed for FY 2025, the company reported a revenue of ₹29.21 Lakh, a growth of 46% compared to the previous year. For the same year it recorded a net profit of ₹5,095 (net margin 0.2%) and EBITDA of ₹34,360 (EBITDA margin 1.2%).
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Macrolive Pharma Private Limited's registered office is in Ghaziabad, Uttar Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address959 2nd Floor Shakti Khand – 4 Indirapuram Ghaziabad, Uttar Pradesh, India – 201014
- IndustryHealthcare, X-Ray Apparatus, Medical & Surgical Equipment, Manufacturing, Orthopedic Appliances, Medical Appliances And Instruments
To see the full contact details of Macrolive Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Macrolive Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Macrolive Pharma Private Limited, buy the company report.
Financials of Macrolive Pharma Private Limited
FY 2025 filings availableMacrolive Pharma Private Limited reported revenue of ₹29.21 Lakh (up 46% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 46% in the latest year. EBITDA fell 46% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹34,360 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹5,095 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.2% | ||||
| Net Profit Margin | 0.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Macrolive Pharma Private Limited, buy the company report.
Board of directors of Macrolive Pharma Private Limited
Macrolive Pharma has 2 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Madhur Rajput | Director | 26 Apr 2023 | 3 Years 6 Months | Current |
| Jaya Rajput | Director | 26 Apr 2023 | 3 Years 6 Months | Current |
Peer comparison
Macrolive Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Leoflex Private Limited | ₹29.24 Lakh (FY 2024) | 2161.0% | Pithampur, Madhya Pradesh, India | |||
| Hahnemann Life Care Private Limited | ₹29.23 Lakh (FY 2025) | 34.0% | Kolkata, West Bengal, India | |||
| Superb Poly Tech Components Private Limited | ₹29.22 Lakh (FY 2023) | -15.0% | New Delhi, Delhi, India | |||
| Futureline Enterprises Private Limited | ₹29.22 Lakh (FY 2018) | 1172.0% | Mangalore, Karnataka, India | |||
| Teximco Enterprise Private Limited | ₹29.22 Lakh (FY 2024) | 82.0% | Kolkata, West Bengal, India | |||
| Macrolive Pharma Private Limitedthis company | ₹29.21 Lakh (FY 2025) | ₹5,095 | 0.2% | 46.0% | Ghaziabad, Uttar Pradesh, India | |
| Carbine Enterprises Private Limited | ₹29.21 Lakh (FY 2024) | -79.0% | Mumbai, Maharashtra, India | |||
| Khajit Chem Private Limited | ₹29.21 Lakh (FY 2025) | -37.0% | Ahmedabad, Gujarat, India | |||
| Saviour Biotech Private Limited | ₹29.21 Lakh (FY 2021) | -82.0% | New Delhi, Delhi, India | |||
| Hope Water Ventures Private Limited | ₹29.2 Lakh (FY 2024) | 88.0% | Kottayam, Kerala, India | |||
| Cion Foods Private Limited | ₹29.2 Lakh (FY 2022) | 39.0% | Hisar, Haryana, India |
To see the full peer comparison of Macrolive Pharma Private Limited, buy the company report.
Auditor
Macrolive Pharma Private Limited is audited by GOELVIKAS SHILPI & CO. for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| GOELVIKAS SHILPI & CO. | FY 2017 | 013729C |
Shareholding
The shareholding of Macrolive Pharma Private Limited is on record for FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Macrolive Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Macrolive Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Macrolive Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Macrolive Pharma has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAKCM1428P2ZW | Uttar Pradesh | Active | 23 Feb 2021 |
To see the full GST registrations and return filing status of Macrolive Pharma Private Limited, buy the company report.
Recent activity
Macrolive Pharma Private Limited has 7 board changes on record since 2019: 2 appointments and 5 cessations. The latest: Meenu ceased to be Director on 29 Apr 2023.
Frequently asked questions
Macrolive Pharma is an active private limited company based in Ghaziabad, Uttar Pradesh, India. The company works in x-ray apparatus, within the healthcare industry. It was incorporated on 04 February 2016 (10+ years old) and is registered under CIN U33111UP2016PTC076264.
Macrolive Pharma has 2 current directors:
- Madhur Rajput - Director
- Jaya Rajput - Director
The latest financial statements of Macrolive Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Macrolive Pharma is 09AAKCM1428P2ZW, registered in Uttar Pradesh. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Macrolive Pharma is U33111UP2016PTC076264. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Macrolive Pharma was incorporated on 04 February 2016, making it 10+ years old. It is registered with the Registrar of Companies, Kanpur.
The peers of Macrolive Pharma by revenue are Leoflex Private Limited, Hahnemann Life Care Private Limited, Superb Poly Tech Components Private Limited, Futureline Enterprises Private Limited, Teximco Enterprise Private Limited and 5 more, all in the same principal business activity (wholesale trading).
Meenu ceased to be Director on 29 Apr 2023. Varun Kumar ceased to be Director on 29 Apr 2023. Jaya Rajput was appointed as Director on 26 Apr 2023. Macrolive Pharma has 7 board changes on record in total.
The registered office of Macrolive Pharma is at 959 2nd Floor Shakti Khand – 4 Indirapuram Ghaziabad, Uttar Pradesh, India – 201014.
Macrolive Pharma operates in the healthcare industry, in the x-ray apparatus segment.
The compliance status of Macrolive Pharma is compliant as of 17 July 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
